Efficacy of upadacitinib as an induction therapy in severe and refractory ulcerative colitis: sub-group analysis of the phase 2b study U-ACHIEVE

Geert R. D'Haens  1     James Lindsay  2     Edward Loftus  3     Wen Zhou  4     Fabio Cataldi  4     Wangang Xie  4     David Pugatch     Remo Panaccione    
1 Amsterdam University Medical Centers,Amsterdam,Netherlands
2 Centre for Immunobiology, Barts and The London School of Medicine and Dentistry, Queen Mary University of London,London,United Kingdom
3 Mayo Clinic,Rochester,United States
4 AbbVie Inc.,Chicago,United States

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing